The 2013 Geoffrey Beene Global Neurodiscovery Challenge
The Foundation for the National Institutes of Health, inward association amongst the Geoffrey Beene Foundation Alzheimer’s Initiative, denote preliminary winner, finalist for the awards, in addition to opened upwards voting to the public.
 |
| Online Voting begins on Nov 1 in addition to ends of Nov 5 |
Baca Juga
The grand prize winner volition have an additional $50,000 honour to proceed enquiry specifically inward the expanse of male/female differences inward Alzheimer’s disease.
| Subscribe to the |
FNIH AND GEOFFREY BEENE FOUNDATION ALZHEIMER’S INITIATIVE OPEN ONLINE VOTING TO THE PUBLIC FOR THE 2013 GEOFFREY BEENE GLOBAL NEURODISCOVERY CHALLENGE
Informed Public to Help Select Winners Who Will Study
Male/Female Differences inward Alzheimer’s Disease
The Foundation for the National Institutes of Health, inward association amongst the Geoffrey Beene Foundation Alzheimer’s Initiative, today announced the top iv winners of the preliminary circular of the first-ever challenge to position male/female differences inward Alzheimer’s Disease (AD).
The 2013 Geoffrey Beene Global NeuroDiscovery Challenge exceeded expectations inward damage of scientific involvement in addition to global outreach amongst to a greater extent than than 800 opened upwards projection rooms from 65 countries. The iv winners of the kickoff circular volition part $50,000 inward awards from the Geoffrey Beene Foundation Alzheimer’s Initiative.
From Nov 1 – 5, 2013 the populace volition postulate maintain the chance to vote for the grand prize winning entry. The grand prize winner volition have an additional $50,000 honour to proceed enquiry specifically inward the expanse of male/female differences inward Alzheimer’s disease.
The 2013 Geoffrey Beene Global NeuroDiscovery Challenge invited researchers to leverage large sets of clinical information in addition to new analytical approaches to elucidate the causes in addition to consequences of male/female (biologic sex) differences inward the destructive physical changes in addition to atrophy inward the brain, how those changes interpret into progression of physical symptoms in addition to the influence of genetics in addition to hormones on the evolution of AD inward both men in addition to women.
“We are delighted amongst the worldwide reply in addition to involvement to the challenge,” said Maria Freire, Ph.D., President of the FNIH, which manages the partnership for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a pregnant report of the progression of Alzheimer’s Disease that is ane of the nifty success stories of National Institute on Aging/NIH in addition to private-sector funding. “We are encouraging the informed populace to review the finally iii candidates in addition to participate inward this of import first past times voting for a winner.”
“What amend means to inform the scientific discipline in addition to mobilize women than to inquire a enquiry enquiry that matters to them?” says Meryl Comer, President in addition to CEO of the Geoffrey Beene Foundation Alzheimer’s Initiative. “The 2013 Geoffrey Beene Global NeuroDiscovery Challenge supports in addition to validates this enquiry focus for our adjacent generation scientists. It’s fourth dimension to observe out if what’s truthful inward cardiovascular disease, amongst women presenting amongst “atypical” symptoms from men, is every bit good truthful for Alzheimer’s disease.”The iv winners of the kickoff circular are:
Enrico Glaab, PhD – Research Associate at the Grand Duchy of Luxembourg Centre for Systems Biomedicine, University of Luxembourg, (Netherlands).
Age-related gender differences inward encephalon seem levels of tau-interacting ubiquitin-specific peptidase nine in addition to possible implications for Alzheimer’s disease.
Kimberly Glass, PhD in addition to John Quackenbush, PhD – Harvard School of Public Health, Dana-Farber Cancer Institute, (Boston, MA).
Sex-specific differences inward Alzheimer’s illness are characterized past times unique alterations inward cellular network structure.
Elizabeth Mormino, PhD – Massachusetts General Hospital, Department of Neurology, (Boston MA).
Gender in addition to the Alzheimer’s illness pathological cascade.
Herve Rhinn, PhD in addition to Asa Abeliovich, MD, PhD - Department of Pathology,
Columbia University (New York).
Scarb1 every bit a Mediator of Gender-Specific Differences inward Alzheimer’s disease.
Online voting for the grand prize winner runs Nov 1 – 5, 2013 at www.geoffreybeenechallenge.org.
H5N1 alive vote volition every bit good postulate maintain house Nov 7, 2013 at the Alzheimer's Disease Summit: The Path to 2025, presented past times The New York Academy of Sciences, the Global CEO Initiative on Alzheimer's Disease, in addition to the National Institute on Aging/NIH.
The iii candidates’ submissions nether consideration for the grand prize are:
Enrico Glaab, PhD
Kimberly Glass, PhD in addition to John Quackenbush, PhD
Herve Rhinn, PhD in addition to Asa Abeliovich, MD, PhD
Featured speakers at the Nov 7, 2013 Alzheimer's Disease Summit include Maria Freire, President of FNIH, Freda Lewis Hall, Executive Vice President in addition to Chief Medical Officer, Pfizer, Anne Whitaker, President North American Pharmaceutical, CEO Sanofi US, Reisa Sperling, MD, Professor of Neurology, Director, Center for Alzheimer's Research in addition to Treatment, Brigham in addition to Women's Hospital, in addition to Meryl Comer, President of Geoffrey Beene Foundation Alzheimer’s Initiative.
About the Foundation for NIH
Established past times the the States Congress to back upwards the mission of the NIH—improving wellness through scientific regain inward the search for cures—the Foundation for the NIH is a leader inward identifying in addition to addressing complex scientific in addition to wellness issues. The foundation is a not-for-profit, 501(c)(3) charitable scheme that raises private-sector funds for a broad portfolio of unique programs that complement in addition to heighten NIH priorities in addition to activities. For additional information close the Foundation for the NIH, delight see www.fnih.org.
About Geoffrey Beene Foundation Alzheimer’s Initiative
The Geoffrey Beene Foundation Alzheimer’s Initiative—launched inward Nov 2007 in addition to funded alone past times Geoffrey Beene, LLC in addition to the Geoffrey Beene Foundation—has made contributions inward excess of $4.7 meg to back upwards adjacent generation enquiry inward early on diagnostics in addition to groundbreaking awareness programs to bring out the touching on of the Alzheimer’s epidemic on individuals, families in addition to our wellness help system. Contributions include catalyst funding for the National Alzheimer’s Prevention Registry; the award-winning Rock Stars of Science™ campaign; marquis sponsorship of HBO’s “The Alzheimer’s Project” documentary series; co-sponsorship of the Alzheimer’s Challenge 2012; in addition to co-founder of the 21st Century BrainTrust™.
About the 2013 Geoffrey Beene Global NeuroDiscovery Challenge
The 2013 Geoffrey Beene Global NeuroDiscovery Challenge was launched inward association with: Foundation for the National Institutes of Health (FNIH), Institute of Medicine (IOM), Women Against Alzheimer’s Network (WA2), 21st Century BrainTrust™ (21 CBT), BrightFocus Foundation, Brigham & Women’s Hospital, Boston, Mass Bio (600 Biotech Companies), Society for Women’s Health Research (SWHR). The National Institute on Aging/NIH provided technical support.
The 2013 Geoffrey Beene Global NeuroDiscovery Challenge Judging Panel:
- Marietta Anthony, PhD, Consultant inward Women’s Health Research
- Janine Clayton, MD, Director of Women’s Health, NIH (ex-officio capacity)
- Howard Fillit, MD, founding executive manager in addition to main scientific discipline officer, Alzheimer’s Drug Discovery Foundation
- Florence Haseltine, MD, PhD, information technology consultant, founder, Society for Women’s Health Research
- Lenore Launer, PhD, Chief of the Neuroepidemiology Section, NIA
- Freda Lewis-Hall, MD, Executive Vice President in addition to Chief Medical Officer, Pfizer
- Michelle Mielke, PhD, Associate Professor of Epidemiology, Mayo Clinic
- Peter Rabins, MD, MPH, Professor, Department of Psychiatry in addition to manager of the Division of Geriatric Psychiatry in addition to Neuropsychiatry, Johns Hopkins Medicine
- Alan Russell, PhD, founding manager of the University of Pittsburgh’s McGowan Institute for Regenerative Medicine, Carnegie Mellon University
United States, India, United Kingdom, Germany, Canada, Netherlands, Russian Federation, Italy, Poland, Singapore, Israel, Spain, Switzerland, France, Pakistan, Portugal, Brazil, China, Greece, Turkey, Ukraine, Australia, Belgium, Japan, Mexico, Sweden, Colombia, Denmark, Finland, Hong Kong, Jordan, Luxembourg, Malaysia, Serbia, South Africa, Argentina, Armenia, Austria, Belarus, Bulgaria, Croatia, Egypt, Estonia, Hungary, Indonesia, Ireland, Kazakhstan, Kenya, Lithuania, Republic of Macedonia (The Former Yugoslav Republic Of), Madagascar, Moldova (Republic Of), Morocco, Nigeria, Norway, Oman, Peru, Philippines, Puerto Rico, Slovakia, Slovenia, Taiwan , Trinidad in addition to Tobago, Uruguay, in addition to Uzbekistan.
21st Century BrainTrust™ Founding Partners: Geoffrey Beene Foundation Alzheimer’s Initiative, USAgainstAlzheimers(USA2), BrightFocus Foundation, Scientific Partner: Cleveland Clinic/Lou Ruvo Brain Institute.
Related Articles
- What is the Difference Between Alzheimer’s in addition to Dementia
- Test Your Memory for Alzheimer's (5 Best Memory Tests)
- The First Sign of Alzheimer's Short Term Memory Loss
- How to Reduce Memory Loss
- Is Alzheimer's World an Irrational Place?
- Communicating inward Alzheimer's World
- The Seven Stages of Alzheimer's
You are reading master content the
